Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Diffuse large B-cell lymphoma refractory
ADR ID BADD_A07155
ADR Hierarchy
01      Blood and lymphatic system disorders
01.15      Lymphomas non-Hodgkin's B-cell
01.15.02      Diffuse large B-cell lymphomas
01.15.02.003      Diffuse large B-cell lymphoma refractory
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.28      Lymphomas non-Hodgkin's B-cell
16.28.02      Diffuse large B-cell lymphomas
16.28.02.003      Diffuse large B-cell lymphoma refractory
Description Not Available
MedDRA Code 10012822
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
B-immunoblastic lymphoma (Kiel Classification) refractory | B-large cell anaplastic Lymphoma (Kiel Classification) refractory | Centroblastic lymphoma refractory | Diffuse large B-cell lymphoma refractory | Diffuse large cell cleaved lymphoma (Working Formulation) refractory | Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) refractory | Diffuse mixed small and large cell lymphoma (Diffuse large B-cell lymphoma) refractory | Large cell immunoblastic lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) refractory | Reticulosarcoma refractory
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00230Bendamustine0.000168%
BADD_D01253Lenalidomide0.001808%
BADD_D02493Selinexor0.002776%
The 1th Page    1    Total 1 Pages